Page 162 - CW E-Magazine (11-6-2024)
P. 162

MANUFACTURER & SUPPLIER OF                                                                                                                                               News from Abroad
          • ACETYL BROMIDE
          • 2-BROMO ACETYL BROMIDE                                          INDOTECH Speciality Private Limited      EXPANSION
          • PROPIONYL BROMIDE                                                  One of the Largest  Manufacturers of
          • 2-BROMO PROPIONYL BROMIDE                                             Dioctyl Sodium                     Eli Lilly announces new $5.3-bn investment for making
          • BENZYL BROMIDE                                                  Sulphosuccinate (DOSS)                   APIs in Indiana, US
          • ETHYL 2-BROMO ACETATE                                           • Liquid & Paste Form
                                                                                                                        American drug major, Eli Lilly and
          • ETHYL 2-BROMO PROPIONATE                                        • For All Applications                   Company, is planning to more than
          • PHOSPHORUS TRIBROMIDE                                           • In Any Solvent of Customer Choice      double its investment at the Limitless

                    CRYSTLE CHEMIPHARMA                                                contact:                      Exploration  Advanced Pace (LEAP)
                                                                                                                     research and innovation district in
                    Plot No: (3404+3405)/2, Phase - IV, G.I.D.C. Chhatral,   KNS ADI  Shiv Kashi, Plot No. 20, Vivekanand Society,  Lebanon, Indiana, USA.
                       Tal. Kalol, Dist. Gandhinagar, Gujarat - 382729      Tilak Nagar Aurangabad, Maharashtra - 431136
         Email: crystlechemipharma@gmail.com / mukeshprajapatislc@gmail.com     Ph: 8055812141 / 9850260111
                Contact: Mukesh Prajapati: +91 9228162588 / 9737020949         Email: mktg.indotech@gmail.com           The added investment will enhance
                                                                                                                     the company’s capacity to manufacture
                                                                                                                     active pharmaceutical ingredients (API)
                    We offer all grade of following chemicals                                                        for its latest type 2 diabetes and obesity  the single largest investment in synthetic  Alzey, Germany. Separately, Lilly has
       • Antimony Tri Sulphide / Chloride / Penta Chloride  • Potassium Chloride Tech / Pharma  available
       • Antimony Potassium Tartrate    • Potassium Chromate / Di Chromate                                           medicines. The announcement was made  medicine API manufacturing in US history,”  invested an additional $1.2-bn to update
       • Ammonium Chloride Tech / Pharma  • Magnesium Chloride Flakes / Anhydrous                                    during the recently held ‘Indiana 2024  said Lilly Chair and CEO Mr. David  existing manufacturing facilities in
       • Ammonium Di Chromate / Chromate  • Red Phosphorous Ready Stock
       • Aluminium Chloride Anhydrous   • Zinc Chloride Tech / Anhydrous / Pharma / Liquid                           Global Economic Summit’.  The new  Ricks. “This multi-site campus will make  Indianapolis (US).
       • Aluminium Isopropoxide         • Zinc Sulphate Hepta / Mono / Pharma                                        $5.3-bn expansion brings Lilly’s total  our latest medicines, support pipeline
       • Benzoyl Chloride               • Tertiary Butyl Hydro Peroxide (TBHP)  phenol
       • Barium Chloride                • Di Tertiary Butyl Peroxide (DTBP)                                          LEAP investment to $9-bn.         growth and leverage the latest technology   In  May  2022,  Lilly  fi rst  announced
       • Calcium Chloride Lumps / Powder /   • Tertiary Butyl Per Benzoate (TBPB)                                                                      and automation for maximum effi ciency,  its plans to invest $2.1-bn at LEAP.
        Pharma / Anhydrous / Liquid
       • Calcium Hydroxide Pharma       • Tertiary Butyl Proxy-2-Ethyl Hexanoate (TBPEH)                                LEAP district is modelled after the  safety and quality control,” he added.  At the company’s Lebanon groundbreaking
       • Calcium Carbonate PPT / ACT    • Methyl Ethyl Ketone Peroxide (MRKP)           on                           Research  Triangle Park in North Caro-                              in April 2023, Lilly announced an addi-
       • Copper Sulphate Crystals / Anhydrous / Pharma  • Tetra Butyl Ammonium Bromide
       • Ferric Chloride Anhydrous / Pharma / Liquid  • Thiophenol                                                   lina as a hub of global innovation with   Since 2020, Lilly has committed  tional $1.6-bn investment. Since breaking
       • Ferrous (Iron) Sulphide Lumps / Powder / Sticks  • Sodium Iodide / Potassium Iodide                         land ready to parcel for manufacturing  more than $16-bn to develop new manu-  ground at LEAP, Lilly has transformed a
       • Ferrous Sulphate Hepta / Mono / Pharma  • Phenyl Propyl Alcohol     regular basis
       • Lead Acetate / Nitrate / Chloride /    • Cyclohexyl Salicylate                                              or R&D facilities or corporate campuses.  facturing sites in the US and Europe.  signifi cant portion of its 600 acres at the
        Chromate / Carbonate / Sulphate  • Methyl Abietate                                                           “This announcement tops the largest  New locations outside of Indiana include  site into an active construction site and
       • Sodium Acetate Trihydrate / Anhydrous   • Meta Nitro Benzaldehyde
                Contact Manufacturers: Anron Chemicals Co.                                                           manufacturing investment in our com-  Research  Triangle  Park  and Concord,  expects to begin making medicines there
                An ISO 9001 Company | Celebrating Silver Jubilee | Established -1996  contact: 7208319309            pany’s history and, we believe, represents  North Carolina; Limerick, Ireland; and  in late 2026.
              401, Sujata Chambers, 4th Floor, 1/3, Abhaychand Gandhi Marg, Mumbai- 400009.
                   Tel : +91-22-66352608, 62372003 | Cell : 9820137343 | 9152609250  email: g2thorat@gmail.com       CONSOLIDATION
         Email: info@anronchemical.com | anronpawar@gmail.com | Visit us: www.anronchemical.com
                                                                                                                     Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1-bn
                      Distributors for Henan Jindan Lactic Acid Technology Co., China
                                                                                                                        Japanese chemicals conglomerate,  boards of both companies. The offer of  and related diseases. Japanese companies
                       lactic acid   sodiuM lactate   calciuM lactate                                                Asahi Kasei, has offered to buy Swedish  208 crowns per share represents an 83%  have been looking for growth outside
                                          l
                                                                        l
        lactic acid powder   MaGnesiuM lactate   buffered lactic acid                                                drugmaker Calliditas  Therapeutics, for  premium on Calliditas’ price of 113.6  their home market and in areas such as
                                                                      l
                                      l
       acrYlonitrile   di cYclo pentadiene   itaconic acid   GlYoXal 40%   potassiuM bi carbonate                    around $1.1-bn as it looks to turn itself  crowns.                  healthcare to offset declining revenue at
                       l
                                                                              l
                                                              l
                                                                                                                                                                                         home as the population ages and shrinks
                                                                                                                     into a global player in pharmaceuticals.
                                              l
                             l
         l  Acrylamide  Acrylic Acid    Di Methyl sulphoxide    l  Formic Acid     Methane sulphonyl Chloride (MsC)                                       Calliditas focuses on orphan diseases  in the world’s fourth largest economy.
                  l
                                                                              l
         l   Butyl Carbitol     Ethyl Acrylate          hydroxylamine sulfate (hAs)     Methyl Propyl Ketone - 99.9%    A maker of specialised chemicals,  and patients with unmet medical needs.
                             l
                                                     l
                                                                              l
                                                                              l
                             l
         l  Butylated hydroxy toluene    2-Ethyl hexyl Acrylate (2EhA)    L(+)tartaric Acid     N-Methyl Pyrrolidone (NMP)  including those  used  in batteries,  the  In recommending that shareholders   Calliditas’ product, Tarpeyo, is highly
                                                     l
                                      l
         l  Butylated hydroxy Anisole    L-Lysine   L-Glycine     Methylene Di Chloride     Paraformaldehyde 91% & 96%  fi rm is best known in Japan for its building  accept the tender  offer,  the  Calliditas  complementary to  Asahi Kasei’s exist-
                             l
                                                                              l
                                                     l
                             l
         l  Bisphenol A         L-Alanine               Methyl Methacrylate (MMA)     Potassium Carbonate Powder     materials, such as insulation used in  board said in a statement that the company  ing geographic and therapeutic areas and
                                                                              l
                                                     l
          Cyclohexanone        l  L-Glutamic Acid       Methacrylic Acid (MAA)    sodium Formate                     housing. It has a pharma division, but is  stands  to  “realise  the  benefi ts  of  being  treats a rare disease called IgA nephro-
       l
                                                     l
                                                                              l
          Di Methyl Carbonate     L-Arginine   humic Acid    Methane sulphonic Acid (MsA)    tetrahydrofuran (thF)   not heavyweight in the industry.  part of a larger platform”.       pathy, currently the only fully approved
                             l
       l
                                        l
                                                     l
                                                                              l
                                                                                                                                                                                         product shown to reduce the loss of
                    Please Contact:                             Importers & Dealers in: Chemicals & General Merchandise  Asahi Kasei said it would offer about   Asahi Kasei said it wants to expand  kidney function in adults with primary
                    D/501, Neelkanth Business Park, Behind Bus Depot, Vidyavihar (West), Mumbai 400 086.             11.8-bn Swedish crowns ($1.1-bn) for  its healthcare operations globally in the  immunoglobulin A nephropathy who are
                    Tel.: 022-61271617 / 1618  l Telfax: 022- 25151500 / 35100110  l M.: 9967186874 / 9892821414 / 9223383831   Calliditas,  in  a  deal  approved  by  the  fi elds  of  immunology,  transplantation  at risk for disease progression.
                    Email: operations@nishachemicals.com  l Website: www.nishachemicals.com
       23/46
       162                                                                     Chemical Weekly  June 11, 2024        Chemical Weekly  June 11, 2024                                                                  163
                                      Contents    Index to Advertisers    Index to Products Advertised
   157   158   159   160   161   162   163   164   165   166   167